BiotechTube
Home/Medivir/Pernilla Sandwall
PS

Pernilla Sandwall

Chief Financial Officer & Head of Operations (CFO)

Medivir

Therapeutic Areas

OncologyLiver Cancer

Medivir Pipeline

DrugIndicationPhase
Fostroxacitabine bralpamide (MIV-818)Hepatocellular Carcinoma (HCC)Phase 2a
Protease Inhibitor Discovery ProgramsOncology (Undisclosed)Discovery
Nucleoside/Nucleotide Discovery ProgramsOncology (Undisclosed)Discovery

Leadership Team at Medivir

JL
Jens Lindberg
Chief Executive Officer (CEO)
FÖ
Fredrik Öberg
Chief Medical Officer (CMO)
UH
Uli Hacksell
Chairman of the Board
View full Medivir profile